Distribution of serotonin receptor of type 6 (5-HT6) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study

Neurochemical Research

Volumn 37, Issue 5, 2012, Pages 920-927

  Marazziti, Donatella ^a   Baroni, Stefano ^a   Pirone, Andrea ^a   Giannaccini, Gino ^a   Betti, Laura ^a   Schmid, Lara ^a   Vatteroni, Elena ^a   Palego, Lionella ^a   Borsini, Franco ^b   Bordi, Fabio ^b   Piano, Ilaria ^c   Gargini, Claudia ^a   Castagna, Maura ^a   Catena Dell'Osso, Mario ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Sigma Tau SpA   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

125I SB 258585 binding; Autopsy; Autoradiography; Human brain; Immunofluorescence; Immunohistochemistry; Serotonin; Serotonin receptors; Serotonin receptors of type 6

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IODINE 125; PARVALBUMIN; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR;

ARTICLE; ASTROCYTE; AUTOPSY; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CORPUS STRIATUM; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NERVE CELL; NUCLEUS ACCUMBENS; PERIKARYON; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUTAMEN; RECEPTOR DENSITY;

AUTORADIOGRAPHY; BRAIN; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; PIPERAZINES; POSTMORTEM CHANGES; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SULFONAMIDES;

EID: 84862835777     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0684-y     Document Type: Article

References (57)

1. Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355-366
2. Stahl SM (2008) Essential neuropsychopharmacology - neuroscientific basis and pratical applications. Cambridge University Press, Cambridge
3. Clark L, Roiser JP, Cools R, Rubinsztein DC, Sahakian BJ, Robbins TW (2005) Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 182(4):570-578 (Pubitemid 41464639)
4. Nordquist N, Oreland L (2010) Serotonin, genetic variability, behaviour, and psychiatric disorders - a review. Ups J Med Sci 115(1):2-10
5. 6 serotonin receptor. J Neurochem 66:47-56 (Pubitemid 26010763)
6. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993) Cloning and expression of a novel serotonin receptor with affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:320-327 (Pubitemid 23081986)
7. Roth BL, Craigo SC, Choudhary MS, Uluier A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding to typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403-1410 (Pubitemid 24100360)
8. Glatt CE, Snowman AM, Sibley DR, Snyder SH (1995) Clozapine: selective labeling of sites resembling 5-HT6 serotonin receptors may reflect psychoactive profile. Mol Med 1(4):398-406
9. Frederick JA, Meador-Woodruff JH (1999) Effect of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain. Schizophr Res 38(1):7-12 (Pubitemid 29333596)
10. Branchek TA, Blackburn TP (2000) 5-HT6 receptors as emerging targets for drug discovery. Ann Rev Pharmacol 40:319-334 (Pubitemid 30340685)
11. Bymaster FP, Falcone JF, Bauzon D, Kennedy JS, Schenk K, DeLapp NW, Cohen ML (2001) Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine. Eur J Pharmacol 430:341-349 (Pubitemid 33050060)
12. Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27(7):1159-1172 (Pubitemid 37464960)
13. Healy DJ, Meador-Woodruff JH (1999) Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain. Neuropsychopharmacology 21:341-351 (Pubitemid 29333072)
14. 125I]SB-258585. Synapse 45:191-199 (Pubitemid 34827362)
15. King MV, Fone KCF, Shacham S, Gannon KS (2007) The novel 5-HT6 antagonist, PRX-07034, enhances memory and reduces food intake in a neurodevelopmental model of schizophrenia. J Psychopharmacol 21:A57
16. Leng A, Ouagazzal A, Feldon J, Higgins GA (2003) Effect of the 5-HT6 receptor antagonists Ro 04-6790 and Ro 65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacol Biochem Behav 75:281-288 (Pubitemid 36859812)
17. Minabe Y, Shirayama Y, Hashimoto K, Routledge C, Hagan JJ, Ashny CR Jr (2004) Effect of acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 52:20-28 (Pubitemid 38316267)
18. 6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Brain Res 1134:70-78 (Pubitemid 46135533)
19. 6 receptor antagonist of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine. Pharmacol Biochem Behav 88:291-298 (Pubitemid 350116256)
20. Pouzet B, Didriksen M, Arnt J (2002) Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol Biochem Behav 71:635-643 (Pubitemid 34219214)
21. 6 receptor antagonist: comparison among antipsychotics. Neuropsychopharmacology 33:2657-2666
22. Hedo G, Lopez-Garcia JA (2002) 5-HT1B but not 5-HT6 or 5-HT7 receptors mediate depression of spinal nociceptive reflexes in vitro. Brit J Pharmacol 135:935-942 (Pubitemid 34214452)
23. Castaneda-Corral G, Rocha-Gonzales HI, Araiza-Saldana CI, Ambriz-Tututi M, Vidal-Cantù GC, Granados-Soto V (2009) Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test. Neurosci 162:444-452
24. 6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology 42:170-180 (Pubitemid 34137020)
25. Dawson AL, Li P (2003) Effects of 5-HT6 receptor blockade in the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat. J Neural Transm 110:577-590 (Pubitemid 36683512)
26. Kindlundh AMS, Svenningsson P, Schioth HB (2006) Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected by intermittent administration of MDMA in rat brain. Neuropharmacology 51:838-847 (Pubitemid 44286936)
27. 6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Biol Psychiatry 63:207-213 (Pubitemid 350299315)
28. Pitsikas N, Zisopoulou S, Pappas I, Sakellaridis N (2008) The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor anatagonist MK-801. Behav Brain Res 188:304-309
29. Di Chiara G, Valentini V, Fenu S, De Luca MA, Borsini F (2009) Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulants? Behav Pharmacol 20:S9
30. Morairty SR, Hedley L, Flores J, Martin R, Kilduff TS (2008) Selective 5-HT2A and 5-HT6 receptor antagonists promote sleep in rats. Sleep 31(1):34-44
31. Routledge C, Bromidge SM, Moss SF, Price GW, Hirst W, Newmann H, Riley G, Gager T, Stean T, Upton U, Clarke SE, Brown AM, Middlemiss DN (2000) Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist. Brit J Pharmacol 130:1606-1612 (Pubitemid 30611938)
32. 7 serotonergic receptor recruitment in tonic-clonic seizure-induced antinociception: role of dorsal raphe nucleus. Exp Neurol 217:16-24
33. Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RHP, Bos M (2003) Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4- sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46:1273-1276 (Pubitemid 36428233)
34. Johnson CN, Ahmed M, Miller ND (2008) 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia. Curr Opin Drug Discov Devel 11(5):642-654
35. 6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 5:458-469 (Pubitemid 351952494)
36. 6 receptor antagonists for the treatment of Alzheimer's disease. Curr Top Med Chem 8:1035-1048
37. Geldenhuys WJ, Van der Schyl CJ (2009) The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease. Expert Rev Neurother 9:1073-1085
38. Witty D, Ahmed M, Chuang T-T (2009) Advances in the design of 5-HT6 receptor ligands with therapeutical potential. Progress Med Chem 48:163-225
39. Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, Davy M, Williams P (2009) Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457. Curr Alzheimer Res. 2010 7(5):374-385
40. Rossé G, Schaffhauser H (2010) 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. Curr Topics Med Chem 10:207-221
41. 6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol Ther 117:207-231
42. 6 receptor-like material in the rat central nervous system. Brain Res 746:207-219 (Pubitemid 27060349)
43. 6 receptor subtype in the rat brain. Life Sci 62:1471-1473
44. 6 receptors. Neuropsychopharmacology 21:68S-76S
45. 6 receptors in rat, pig, and human brain tissue. Brit J Pharmacol 130:1597-1605 (Pubitemid 30611937)
46. Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (2003) Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modelling. Mol Pharmacol 64:1295-1308 (Pubitemid 37532219)
47. 125I]SB-258585. Brain Res 934:49-57 (Pubitemid 34286567)
48. Ward RP, Hamblin MW, Lachowicz JE, Hoffman BJ, Sibley DR, Dorsa DM (1995) Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neurosci 64:1105-1111
49. Gerard C, El Mestkawy S, Lebrand C, Adrien J, Ruat M, Traiffort E, Hamon M, Martres M-P (1996) Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5, 7-dihydroxytryptramine-treated rats. Synapse 23:164-173 (Pubitemid 26230563)
50. Nieuwenhuys R (1985) Chemoarchitecture of the brain. Springer, Verlag. Berlin Heidelberg New York
51. McPherson GA (1985) Kinetic. In: Lowry A (ed) Collection of radioligand binding analysis programs
52. Cheng YC, Prusoff WH (1973) Relation between the inhibition constant Ki and the concentration of inhibitor which causes fifty per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
53. Wesolowska A (2010) Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data. Pharmacol Rep 62(4):564-577
54. Groenewegen HJ (2003) The basal ganglia and motor control. Neural Plast 10(1-2):107-120
55. Marazziti D, Baroni S, Catena-Dell'Osso M, Bordi F (2011) Borsini Serotonin receptors of type 6 (5-HT6): what can we expect from them? Curr Med Chem 18(18):2783-2790
56. Harrison PJ (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174(1):151-162 (Pubitemid 38925100)
57. Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18(2):63-101 (Pubitemid 28026679)